Jessica Vanhoy has joined Vestaron as the company’s as chief financial officer. Most recently director of financial planning and analysis for Dova Pharmaceuticals, Vanhoy has 20 years of experience in accounting and finance, fostering teamwork through company growth. She holds a bachelor’s degree in accounting from Appalachian State University and an MBA from Campbell University, and is a certified public accountant in the state of North Carolina.
“As the organization continues to transition from an R&D-focused company to a commercial one, the role of CFO is vital,” says Anna Rath, Vestaron’s CEO. “We look forward to Jessica joining the team as she brings outstanding capabilities in using financial planning and analysis to partner with the business and drive results.”
“With the recent receipt of a new mode of action code from the Insecticide
Resistance Action Committee and potential peptide molecules in development, it is an exciting time to become the newest Vestaron employee,” says Vanhoy.
.jpg)